DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018605
NDA 018605 describes AZULFIDINE, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. It is available from five suppliers. Additional details are available on the AZULFIDINE profile page.
The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Summary for 018605
| Tradename: | AZULFIDINE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | sulfasalazine |
| Patents: | 0 |
| Therapeutic Class: | Inflammatory Bowel Disease Agents |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 018605
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
